202 related articles for article (PubMed ID: 37626912)
21. Value of Electrocardiography to Distinguish Fabry Disease from Sarcomeric Hypertrophic Cardiomyopathy.
Antezana-Chavez E; Cianciulli TF; Hadid CL; Toro DD; Celano L; Saccheri MC; Baez KG; Lopez CA; Labadet CD; Gagliardi JA
Am J Cardiol; 2022 Sep; 178():131-136. PubMed ID: 35810008
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy.
Xiao Y; Sun Y; Tian T; Wang TJ; Zhao RX; Zhang Y; Wang LP; Liu YX; Lu CX; Zhou XL; Yang WX
Am J Med Sci; 2021 Sep; 362(3):260-267. PubMed ID: 34266644
[TBL] [Abstract][Full Text] [Related]
23. Globotriaosylceramide-induced reduction of K
Rickert V; Kramer D; Schubert AL; Sommer C; Wischmeyer E; Üçeyler N
Exp Neurol; 2020 Feb; 324():113134. PubMed ID: 31778662
[TBL] [Abstract][Full Text] [Related]
24. Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal.
Del Franco A; Iannaccone G; Meucci MC; Lillo R; Cappelli F; Zocchi C; Pieroni M; Graziani F; Olivotto I
Heart Fail Rev; 2024 Mar; 29(2):431-444. PubMed ID: 38006470
[TBL] [Abstract][Full Text] [Related]
25. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.
Janczewska-Kazek E; Marek B; Kajdaniuk D; Borgiel-Marek H
World J Gastroenterol; 2006 Feb; 12(6):961-5. PubMed ID: 16521228
[TBL] [Abstract][Full Text] [Related]
26. The clinical utility of total concentration of urinary globotriaosylsphingosine plus its analogues in the diagnosis of Fabry disease.
Alharbi FJ; Baig S; Rambhatla SB; Vijapurapu R; Auray-Blais C; Boutin M; Steeds R; Wheeldon N; Dawson C; Geberhiwot T
Clin Chim Acta; 2020 Jan; 500():120-127. PubMed ID: 31654629
[TBL] [Abstract][Full Text] [Related]
27. Sustained AT
Duangrat R; Parichatikanond W; Morales NP; Pinthong D; Mangmool S
Eur J Pharmacol; 2022 Dec; 937():175384. PubMed ID: 36372276
[TBL] [Abstract][Full Text] [Related]
28. Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy.
Sanchez-Niño MD; Sanz AB; Carrasco S; Saleem MA; Mathieson PW; Valdivielso JM; Ruiz-Ortega M; Egido J; Ortiz A
Nephrol Dial Transplant; 2011 Jun; 26(6):1797-802. PubMed ID: 20504837
[TBL] [Abstract][Full Text] [Related]
29. Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy.
Akhan O; Kış M; Güzel T; Zoghi M
Arq Bras Cardiol; 2024 Jan; 121(1):e20230229. PubMed ID: 38324858
[TBL] [Abstract][Full Text] [Related]
30. 2021 TSOC Expert Consensus on the Clinical Features, Diagnosis, and Clinical Management of Cardiac Manifestations of Fabry Disease.
Hung CL; Wu YW; Lin CC; Lai CH; Jyh-Ming Juang J; Chao TH; Kuo L; Sung KT; Wang CY; Wang CL; Chu CY; Yu WC; Hou CJ
Acta Cardiol Sin; 2021 Jul; 37(4):337-354. PubMed ID: 34257484
[TBL] [Abstract][Full Text] [Related]
31. Plasma Globotriaosylsphingosine Level as a Primary Screening Target for Fabry Disease in Patients With Left Ventricular Hypertrophy.
Yamashita S; Saotome M; Satoh H; Kajihara J; Mochizuki Y; Mizuno K; Nobuhara M; Miyajima K; Kumazawa A; Tominaga H; Takase H; Tawarahara K; Wakahara N; Matsunaga M; Wakabayashi Y; Matsumoto Y; Terada H; Sano M; Ohtani H; Urushida T; Hayashi H; Ishii S; Maruyama H; Maekawa Y
Circ J; 2019 Aug; 83(9):1901-1907. PubMed ID: 31308318
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of Fabry nephropathy: The pathways leading to fibrosis.
Rozenfeld PA; de Los Angeles Bolla M; Quieto P; Pisani A; Feriozzi S; Neuman P; Bondar C
Mol Genet Metab; 2020 Feb; 129(2):132-141. PubMed ID: 31718986
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and Management of Cardiovascular Involvement in Fabry Disease.
Rubino M; Monda E; Lioncino M; Caiazza M; Palmiero G; Dongiglio F; Fusco A; Cirillo A; Cesaro A; Capodicasa L; Mazzella M; Chiosi F; Orabona P; Bossone E; Calabrò P; Pisani A; Germain DP; Biagini E; Pieroni M; Limongelli G
Heart Fail Clin; 2022 Jan; 18(1):39-49. PubMed ID: 34776082
[TBL] [Abstract][Full Text] [Related]
34. Role of cardiac imaging in Anderson-Fabry cardiomyopathy.
Serra W; Marziliano N
Cardiovasc Ultrasound; 2019 Jan; 17(1):1. PubMed ID: 30674321
[TBL] [Abstract][Full Text] [Related]
35. Application of Genetic Testing in Unveiling the Diagnosis of Fabry Disease in a Patient with Hypertrophic Cardiomyopathy.
Gedela M; Sharma R; DeBerg K; Stanton C
S D Med; 2021 Apr; 74(4):150-152. PubMed ID: 34432960
[TBL] [Abstract][Full Text] [Related]
36. Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.
Graziani F; Lillo R; Biagini E; Limongelli G; Autore C; Pieroni M; Lanzillo C; Calò L; Musumeci MB; Ingrasciotta G; Minnucci M; Ditaranto R; Milazzo A; Zocchi C; Rubino M; Lanza GA; Olivotto I; Crea F
Int J Cardiol; 2022 Dec; 369():29-32. PubMed ID: 35931207
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance.
Smid BE; Hollak CE; Poorthuis BJ; van den Bergh Weerman MA; Florquin S; Kok WE; Lekanne Deprez RH; Timmermans J; Linthorst GE
Clin Genet; 2015 Aug; 88(2):161-6. PubMed ID: 25040344
[TBL] [Abstract][Full Text] [Related]
38. Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis.
Seo J; Kim M; Hong GR; Kim DS; Son JW; Cho IJ; Shim CY; Chang HJ; Ha JW; Chung N
J Hum Genet; 2016 Sep; 61(9):775-80. PubMed ID: 27225851
[TBL] [Abstract][Full Text] [Related]
39. Multiplex analysis of novel urinary lyso-Gb3-related biomarkers for Fabry disease by tandem mass spectrometry.
Lavoie P; Boutin M; Auray-Blais C
Anal Chem; 2013 Feb; 85(3):1743-52. PubMed ID: 23248976
[TBL] [Abstract][Full Text] [Related]
40. Serial measurement of vascular endothelial growth factor and transforming growth factor-beta1 in serum of patients with acute ischemic stroke.
Slevin M; Krupinski J; Slowik A; Kumar P; Szczudlik A; Gaffney J
Stroke; 2000 Aug; 31(8):1863-70. PubMed ID: 10926948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
